Concepedia

Michele Tomanelli

MT

Statistics

Publications

2

Citations

75

H-Index

2

Active since

2018

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Michele Tomanelli is an author at Mario Negri Institute for Pharmacological Research specializing in molecular oncology, protein kinase inhibitors, and targeted cancer therapy.

ORCID

Publications per year

2018–2019

2

Publications

2

LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors

Elisa Caiola, Alice Iezzi, Michele Tomanelli et al. · Journal of Thoracic Oncology · 2019 · 47 citations

, , +8

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib

Elisa Caiola, Roberta Frapolli, Michele Tomanelli et al. · Scientific Reports · 2018 · 28 citations · Full text

, , +15

1–2 of 2